Successful use of an inhalational phytochemical to treat pulmonary tuberculosis: A case report
Summary
Multi-drug resistant strains of tuberculosis pose a serious threat in many third- and first-world countries. The aim of this case report is to describe a potential new method for treating those with primary pulmonary tuberculosis using phytochemicals via inhalation.
We report the first case of using inhaled phytochemicals in treating primary pulmonary tuberculosis. A 28-year-old female presented with symptoms suggestive of primary pulmonary tuberculosis, and she was found to be positive via chest X-ray and sputum culture. She subsequently underwent treatment with conventional DOTS treatment.
Ten days post-inhalation of the phytochemical, the patient is tuberculosis negative (via sputum culture), with no clinical symptoms. This may be a potential new method and type of treatment for pulmonary tuberculosis.
No full text is available. To read the body of this article, please view the PDF online.
aDepartment of Orthopaedic Surgery, Nepean Hospital, Penrith, New South Wales, Australia
bDept of Oral and Maxillofacial Surgery (Head: Prof. Dr. Dr. F. Haerle), University of Kiel, Germany
E. Sherry, Department of Orthopaedic Surgery, The University of Sydney, Nepean Hospital, Level 5, South Block, P.O. Box 63, Penrith, NSW 2751, Australia; Tel.: ++61-2 47 315 388; Fax: ++61-2 47 212 128
ABSTRACT